Publications by authors named "Crystal S Seldon"

Claim this Profile
P
Patient and physician attitudes towards salvage stereotactic radiosurgery or radiotherapy for brain metastases.
Benjamin J Rich, Timoteo Almeida, Jared A Maas, Shahil Mehta, Raj Singh, Crystal S Seldon

J Radiosurg SBRT· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations predictive of poor clinical outcomes in pan-cancer.
Crystal S Seldon, Karthik Meiyappan, Hannah Hoffman, Jimmy A Guo, Neha Goel

Oncotarget· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Radiotherapy for Prevention of Heterotopic Ossification After Periacetabular Fractures: A Review of Efficacy and Associated Conditions.
Joseph S Geller, Paul R Allegra, Crystal S Seldon, Benjamin O Spieler, Lara L Cohen

J Surg Orthop Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Musculoskeletal Metastasis From Soft-tissue Sarcomas: A Review of the Literature.
Juan Pretell-Mazzini, Crystal S Seldon, Gina D'Amato, Ty K Subhawong

J Am Acad Orthop Surg· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Versus Secondary Radiotherapy for Heterotopic Ossification Prevention About the Elbow.
Joseph S Geller, Paul R Allegra, Crystal S Seldon, Benjamin O Spieler, Lara L Cohen

J Orthop Trauma· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy-Phase 2 Trial Secondary Analysis.
Robert H Press, Joseph W Shelton, Chao Zhang, Quang Dang, Sibo Tian, Crystal S Seldon

Int J Part Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas.
Crystal S Seldon, Lauren E Colbert, William A Hall, Sarah B Fisher, David S Yu

World J Gastrointest Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis